Report
Tony Sherlock
EUR 100.00 For Business Accounts Only

Moderation in Dwelling Price to Impact Ryman’s Development Profits. FVE cut 4% to NZD 13

Narrow-moat-rated Ryman Healthcare reported first-half fiscal 2019 earnings of NZD 19.3 cents per security and guided to full-year earnings of NZD 44.6 to 47.6 cps. Our forecasts sit in the middle of the guidance range, having been trimmed to NZD 45.8 cps from NZD 46.7 cps to account for rising nurses' wages. We also trimmed the expected profit Ryman makes on newly developed independent living units, or ILU, as dwelling prices in Australia have fallen faster than anticipated, down roughly 10% ov...
Underlying
RYMAN HEALTHCARE LTD.

Ryman Healthcare develops, owns and operates integrated retirement villages, resthomes and hospitals for the elderly within New Zealand and Australia.

Provider
Morningstar
Morningstar

Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. The company offer an extensive line of products and services for individual investors, financial advisors, asset managers, and retirement plan providers and sponsors.

Morningstar provides data on approximately 530,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 18 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. Morningstar also offers investment management services through its investment advisory subsidiaries and had approximately $185 billion in assets under advisement and management as of June 30, 2016.

We have operations in 27 countries.

Analysts
Tony Sherlock

Other Reports on these Companies
Other Reports from Morningstar

ResearchPool Subscriptions

Get the most out of your insights

Get in touch